← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

▼ SELL

$ Value

$92K

Shares

6,053

Price

$15

Filed

Aug 5

Insider

Name

Jover Placid

Title

See "Remarks"

CIK

0002026165

Roles

Officer

Transaction Details

Transaction Date

2025-08-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,774

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.13 to $15.31, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. | Restricted share units were granted on August 1, 2024, with 12,827 vested on August 1, 2025, 12,827 vesting on each of August 1, 2026 and August 1, 2027, and 12,830 vesting on August 1, 2028.

Filing Info

Accession No.

0000950170-25-102992

Form Type

4

Issuer CIK

0000818686

Jover Placid's History

Date Ticker Type Value
2026-03-05 TEVA M
2026-03-05 TEVA $448K
2026-03-05 TEVA M $0
2026-03-04 TEVA A $0
2025-08-01 TEVA M
2025-08-01 TEVA $92K
2025-08-01 TEVA M $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05